HYUNDAI BIOLAND Co.,Ltd.

KOSDAQ:A052260 Stock Report

Market Cap: ₩123.0b

HYUNDAI BIOLANDLtd Balance Sheet Health

Financial Health criteria checks 5/6

HYUNDAI BIOLANDLtd has a total shareholder equity of ₩145.0B and total debt of ₩33.2B, which brings its debt-to-equity ratio to 22.9%. Its total assets and total liabilities are ₩192.8B and ₩47.8B respectively. HYUNDAI BIOLANDLtd's EBIT is ₩11.4B making its interest coverage ratio 20. It has cash and short-term investments of ₩20.6B.

Key information

22.9%

Debt to equity ratio

₩33.22b

Debt

Interest coverage ratio20x
Cash₩20.62b
Equity₩144.99b
Total liabilities₩47.85b
Total assets₩192.83b

Recent financial health updates

Recent updates

HYUNDAI BIOLAND Co.,Ltd.'s (KOSDAQ:052260) Shareholders Might Be Looking For Exit

Dec 17
HYUNDAI BIOLAND Co.,Ltd.'s (KOSDAQ:052260) Shareholders Might Be Looking For Exit

Optimistic Investors Push HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260) Shares Up 27% But Growth Is Lacking

Aug 11
Optimistic Investors Push HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260) Shares Up 27% But Growth Is Lacking

Some Investors May Be Worried About HYUNDAI BIOLANDLtd's (KOSDAQ:052260) Returns On Capital

Jul 26
Some Investors May Be Worried About HYUNDAI BIOLANDLtd's (KOSDAQ:052260) Returns On Capital

Is HYUNDAI BIOLANDLtd (KOSDAQ:052260) A Risky Investment?

May 25
Is HYUNDAI BIOLANDLtd (KOSDAQ:052260) A Risky Investment?

Subdued Growth No Barrier To HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260) With Shares Advancing 28%

May 03
Subdued Growth No Barrier To HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260) With Shares Advancing 28%

Impressive Earnings May Not Tell The Whole Story For HYUNDAI BIOLANDLtd (KOSDAQ:052260)

Mar 19
Impressive Earnings May Not Tell The Whole Story For HYUNDAI BIOLANDLtd (KOSDAQ:052260)

Should You Buy HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260) For Its Dividend?

Apr 12
Should You Buy HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260) For Its Dividend?

HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 08
HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Update: HYUNDAI BIOLANDLtd (KOSDAQ:052260) Stock Gained 14% In The Last Five Years

Feb 15
Update: HYUNDAI BIOLANDLtd (KOSDAQ:052260) Stock Gained 14% In The Last Five Years

The Returns At HYUNDAI BIOLANDLtd (KOSDAQ:052260) Provide Us With Signs Of What's To Come

Jan 28
The Returns At HYUNDAI BIOLANDLtd (KOSDAQ:052260) Provide Us With Signs Of What's To Come

Tread With Caution Around HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) 1.5% Dividend Yield

Jan 10
Tread With Caution Around HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) 1.5% Dividend Yield

HYUNDAI BIOLANDLtd (KOSDAQ:052260) Takes On Some Risk With Its Use Of Debt

Dec 23
HYUNDAI BIOLANDLtd (KOSDAQ:052260) Takes On Some Risk With Its Use Of Debt

Are Poor Financial Prospects Dragging Down HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260 Stock?

Dec 05
Are Poor Financial Prospects Dragging Down HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260 Stock?

The HYUNDAI BIOLANDLtd (KOSDAQ:052260) Share Price Is Up 55% And Shareholders Are Holding On

Nov 17
The HYUNDAI BIOLANDLtd (KOSDAQ:052260) Share Price Is Up 55% And Shareholders Are Holding On

Financial Position Analysis

Short Term Liabilities: A052260's short term assets (₩89.9B) exceed its short term liabilities (₩46.7B).

Long Term Liabilities: A052260's short term assets (₩89.9B) exceed its long term liabilities (₩1.2B).


Debt to Equity History and Analysis

Debt Level: A052260's net debt to equity ratio (8.7%) is considered satisfactory.

Reducing Debt: A052260's debt to equity ratio has reduced from 26.2% to 22.9% over the past 5 years.

Debt Coverage: A052260's debt is not well covered by operating cash flow (5.6%).

Interest Coverage: A052260's interest payments on its debt are well covered by EBIT (20x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 21:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HYUNDAI BIOLAND Co.,Ltd. is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hye Mi KimCape Investment & Securities Co., Ltd.
Jun-Ho ByunEugene Investment & Securities Co Ltd.
Jun-Young ChoiHanwha Investment & Securities Co., Ltd.